New Triple-Threat treatment tested to shrink breast tumors before surgery
NCT ID NCT06178159
Summary
This study is testing whether a new combination of three drugs can safely shrink tumors in people with HER2-positive breast cancer before they have surgery. The treatment aims to eliminate all cancer cells from the breast and lymph nodes by the time of surgery. Researchers will enroll 40 adults with this specific type of breast cancer who haven't had prior cancer treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200433, China
Contact
Conditions
Explore the condition pages connected to this study.